Skip to content

China Medtech Radar

Menu
  • Home
  • Cardiology/Cardiovascular
  • Neurology/Neurovascular
  • Ophthalmology
  • Orthopedics
  • Robotics
  • News & Updates
  • Resources
  • Clinical
  • About
  • Login

Cardiology/Cardiovascular

Notable Cardiac and Cardiovascular Devices and Medical Solutions Approved by NMPA through Fast Track Channel

JUl 31, 2025

Zhongke Yian Medical Technology Launches High-nitrogen Nickel-free Stainless Steel Coronary Stent System

APR 11, 2025

The World’s First Pre-loaded, Dry-packaged TAVR System Approved by NMPA

JUN 30, 2025

World’s First Nanosecond PFA System Received NMPA Approval

FEB 28, 2025

Shanghai Shineyo Medical’s Cardiac PFA System Gains NMPA Approval, Expanding Atrial Fibrillation Treatment Options in China

JAN 22, 2025

ECMO System from Hengrui Medical Has Gained NMPA Approvals

JAN 14, 2025

TeleLife (Anhui Tongling Bionics) Launches TL-IABP-100: A Game-Changer in Cardiovascular Care

Trending


The China MedTech Edge: March 2026 Intelligence Briefing

More to Read


The New Competitive Edge: Clinical-Driven Innovation and the Rise of the Surgeon-Technologist in China’s Medtech Landscape

More to Read


China's $14M Bone 02 Glue: The 3-Minute Miracle Cure or Just an Adhesive Fantasy?

More to Read


High-Precision Technology and Global Strategy Driving China’s Next Wave of MedTech IPOs in 2025

More to Read


Beyond Price Cuts: VBP as a Driver for Innovation and Global Reach in Chinese Medtech

More to Read


Operated by IMPELINNO GmbH, China Medtech Radar is your news aggregator for Medtech innovation in China. Knowledge, Insights & Opportunities, that is what we are all about.

[email protected]
Weyermannsstrasse 36
Bern, 3008
Switzerland

Disclaimer

The information provided on this platform is aimed at providing knowledge and updates as of the date indicated. We make no representations or warranties regarding the accuracy, completeness, or reliability of the content obtained from publicly available information as indicated. By using this information, you acknowledge its potential limitations and assume all risks associated with its use. For more information, please see our full Disclaimer and Terms of Use.

← Back

Thank you for your response. ✨


© 2026 China Medtech Radar | WordPress Theme by Superb WordPress Themes
Back to Top ↑